We need intelligent, scalable systems that lift burdens, illuminate connections, and empower healthcare professionals to deliver their highest-quality care. Agentic AI provides this essential capability. The post Agentic AI and the Architecture of Healthcare Transformation appeared first on MedCity News.
Even the most promising medical advancements struggle to take off in real-world settings without clinician buy-in. Here are some key factors that affect clinician adoption and ways healthtech companies can better position their innovations for success. The post Clinician Adoption: How HealthTech Can Overcome Key Barriers appeared first on MedCity News.
If Legislature adopts proposal, Massachusetts would join California, Oregon and Rhode Island in setting spending targets
Cuando Su Wang estudiaba medicina, donó sangre. Fue entonces cuando se enteró de que estaba infectada con hepatitis B, un virus que ataca el hígado y que puede causar cáncer y la muerte décadas más tarde. “Tenía 18 años, estaba sana, en la universidad”, contó. “Y de repente tenía una enfermedad crónica de la que…
Fortitude Biomedicines is developing antibody drug conjugates that use targeted protein degraders as their therapeutic payloads. The startup joins a group of degrader ADC (or DAC) developers that includes Bristol Myers Squibb and Pfizer. The post Startup Fortitude Bio Launches to Beat Drug Resistance in Cancer, Expand ADCs to Autoimmune Disease appeared first on MedCity…
As health and human services secretary, Robert F. Kennedy Jr. wields one of the louder megaphones the federal government has. Yet he insists he doesn’t want to impose his opinions on Americans. “I don’t think people should be taking medical advice from me,” Kennedy told a Democratic congressman in May. Kennedy once expressed different views…
Sotyktu, which became the first TYK2 inhibitor to reach the market after its 2022 FDA approval in plaque psoriasis, now has positive data from two pivotal tests in psoriatic arthritis. Bristol Myers Squibb is trying to add new indications for the drug and stay ahead of competitors including Takeda Pharmaceutical. The post Bristol Myers Squibb’s…
Kent Dicks, CEO, and Kendall Paulsen, Telehealth Solutions lead, at Life 365 showed me their comprehensive set of tools and services for remote patient monitoring, or what I call the “continuous clinic”. Kent did this with MedApps, later acquired by Alere. But at Life 365 he’s building a new approach to getting the tools and…
[Sponsored] LiveWorld’s white paper, Turning UGC into Insight: The Untapped Value in Pharma Conversations, identifies how moderated conversations become an insight pipeline, and what recurring questions, misinformation themes, and sentiment shifts actually signal. The post How User-Generated Content is Transforming Pharma Insights on the Patient Experience appeared first on MedCity News.
By KIM BELLARD A year ago I wrote about disturbing news from the Pew Research Center that trust in science, and in scientists, had fallen since the pandemic. I am slightly relieved to report that a new follow-up study by Pew indicates that trust is up slightly – but still way below where they were…